Stemline – A Menarini Group Company

Stemline Therapeutics, Inc., a Menarini Group Company is focused on bringing transformational oncology treatments to cancer patients. 

Stemline Therapeutics, Inc., a Menarini Group Company has long admired the breadth of critical work that Komen does to improve outcomes for the patients and families impacted by breast cancer. Stemline Therapeutics supports Komen across local and national initiatives including advancing education through Breast Cancer Breakthroughs, the Real Pink Podcast, and the MBC Impact Series. These efforts include educating people living with metastatic breast cancer and their support partners on ESR1 mutations and biomarker driven cancer treatment.  

About Stemline Therapeutics
Stemline Therapeutics is part of the Menarini Group, a leading international pharmaceutical and diagnostics company. Stemline is committed to applying our scientific leadership to transform the lives of people with cancer. Stemline Therapeutics is continuing to invest in research and conduct clinical trials to advance treatment options available to breast cancer patients. In addition, Stemline is committed to helping patients access medicines and offers reimbursement support and educational resources through Stemline ARC.  

Learn more about Stemline ARC: www.stemlinearc.com